drugset / Trial / NCT03240939

Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil

NCT03240939

Phase 1 Completed 36 enrolled Yuyu Pharma, Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

A randomized, open label, single dose, two-way crossover clinical trial to investigate the pharmacokinetics and safety/tolerability of YY-201 in comparison to Dutasteride and Tadalafil administered in healthy male volunteers

Timeline

Start
2017-03-27
Primary completion
2017-07-07
Completion
2017-10-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dutasteride Small molecule 0.5 mg
Comparator Tadalafil Small molecule 5 mg
Subject YY201 Unknown